Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arrowhead, Atara, Bayer, Bristol Myers Squibb, Celltrion, Eli Lilly, Glaxosmithkline, Janssen, Jupiter, Merck, Olipass, Orion, Polyactive, Regeneron, Sanofi, Takeda.